ROIV

Roivant Sciences Ltd.

Healthcare›Biotechnology|NASDAQ Global Market|GB

Price

$28.33

Market Cap

$20.28B

Beta

1.21

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-56.36%

EPS Growth (YoY)-100.00%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-3.78%

Debt / Equity0.05

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for ROIV.